Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Maysa Abu-Khalaf"'
Autor:
Sameh Gomaa, Carly West, Ana Maria Lopez, Tingting Zhan, Max Schnoll, Maysa Abu-Khalaf, Andrew Newberg, Kuang-Yi Wen
Publikováno v:
JMIR Formative Research, Vol 6, Iss 7, p e40830 (2022)
Externí odkaz:
https://doaj.org/article/40b641477d224f0e816261d5dbcd7178
Autor:
Sameh Gomaa, Carly West, Ana Maria Lopez, Tingting Zhan, Max Schnoll, Maysa Abu-Khalaf, Andrew Newberg, Kuang-Yi Wen
Publikováno v:
JMIR Formative Research, Vol 6, Iss 6, p e34995 (2022)
BackgroundEstrogen receptor–positive breast cancer is the most common type of breast cancer in postmenopausal women. Aromatase inhibitors (AIs) are the endocrine therapy of choice recommended for these patients. Up to 50% of those treated with an A
Externí odkaz:
https://doaj.org/article/717bfa630d6b4296bf0820d5b2845023
Autor:
Mariaelena Pierobon, Johann De Bono, Ruth Riisnaes, Giuseppe Giaccone, Matthew Blackburn, Lance Liotta, Vienna Ludovini, Neil J Shah, Giuseppina Improta, Antonella Ravaggi, Niven Mehra, Angelo Sidoni, Elisa Baldelli, K Alex Hodge, Guido Bellezza, Guido Gambara, Martina Mandarano, Chamodya Ruhunusiri, Bryant Dunetz, Maysa Abu-Khalaf, Julia Wulfkuhle, Rosa I Gallagher, Franco Odicino, Maria Isabella Sereni, Angela Zupa, Perry Demsko, Lucio Crino', Emanuel F Petricoin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/b20bc5349766429ca47d7ba6932e2280
Autor:
Robert Wesolowski, Hope Rugo, Erica Stringer-Reasor, Hyo S. Han, Jennifer M. Specht, E. Claire Dees, Peter Kabos, Ulka Vaishampayan, Seth A. Wander, Janice Lu, Keerthi Gogineni, Alexander I. Spira, Anne F. Schott, Maysa Abu-Khalaf, Pratima Nayak, Brian F. Sullivan, Igor Gorbatchevsky, AND Rachel M. Layman
Publikováno v:
Cancer Research. 83:PD13-05
Background: Addition of PI3K/mTOR inhibitor after progression on CDK4/6 inhibitor (CDK4/6i) and endocrine therapy (ET) can potentially restore sensitivity to CDK4/6i and prevent adaptive activation of the PI3K/mTOR pathway. To evaluate this hypothesi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac22e843acb6326a5f29d832809b9ac3
https://doi.org/10.1158/1538-7445.sabcs22-pd13-05
https://doi.org/10.1158/1538-7445.sabcs22-pd13-05
Autor:
Filipa Lynce, Mervat Saleh, Ayesha Shajahan-Haq, Christopher Gallagher, Asma Dilawari, Olwen Hahn, Maysa Abu-Khalaf, Ling Cai, Paula Pohlmann, Mahsa Mohebtash, Lois Kamugisha, Claudine Isaacs
Publikováno v:
Contemporary Clinical Trials Communications, Vol 10, Iss , Pp 190-192 (2018)
Palbociclib has been shown to be a highly effective therapy in hormone receptor positive metastatic breast cancer when used in combination with letrozole or fulvestrant. Grade 3/4 neutropenia is a common side effect although febrile neutropenia is re
Externí odkaz:
https://doaj.org/article/9a0b85c518604bb989583c7363c99cbf
Autor:
Maysa Abu-Khalaf, Christos Hatzis, K. Alex Hodge, Elisa Baldelli, William Sikov, Monica Mita, Frances Valdes-Albini, Bryant Dunetz, Emanuel Petricoin, Mariaelena Pierobon
Publikováno v:
Cancer Research. 82:P2-07
Background: As part of a multicenter study designed to identify markers of response or resistance to the combination of endocrine therapy (ET) and a cyclin dependent kinase 4/6 inhibitor (CDK 4/6i) as standard 1st-line therapy in patients with hormon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c726a776d879d3edb25dc25188d860c6
https://doi.org/10.1158/1538-7445.sabcs21-p2-07-05
https://doi.org/10.1158/1538-7445.sabcs21-p2-07-05
Autor:
Maysa Abu-Khalaf, Fnu Nikita, Ayako Shimada, Hannah Hackbart, Dina Alnabulsi, Scott Keith, Ana Maria Lopez, Meghan Butryn
Publikováno v:
Cancer Research. 82:P4-11
Background: Obesity is associated with an increased risk of breast cancer recurrence and poor survival. Obesity rate in adults in the city of Philadelphia is high, with non-Hispanic blacks and Hispanics having the highest rates. We sought to evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32fb392207d1a27540851f68f8ca6d14
https://doi.org/10.1158/1538-7445.sabcs21-p4-11-32
https://doi.org/10.1158/1538-7445.sabcs21-p4-11-32
Autor:
Lajos Pusztai, Anees B. Chagpar, Donald Lannin, Erin W. Hofstatter, Maysa Abu-Khalaf, Kelly K. Hunt, Stacy L. Moulder, Rebekah E. Gould, Ya Zhang, W. Fraser Symmans, Christos Hatzis
Purpose: Pathologic complete response (pCR) to neoadjuvant chemotherapy reflects the cytotoxic efficacy of a drug, but patient survival is influenced by many other factors. The purpose of this study was to assess the relationship between increased pC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3458340161d1bcb7a0aa5e3ac6b184ad
https://doi.org/10.1158/1078-0432.c.6524616.v1
https://doi.org/10.1158/1078-0432.c.6524616.v1
Autor:
Lajos Pusztai, Anees B. Chagpar, Donald Lannin, Erin W. Hofstatter, Maysa Abu-Khalaf, Kelly K. Hunt, Stacy L. Moulder, Rebekah E. Gould, Ya Zhang, W. Fraser Symmans, Christos Hatzis
Patient Characteristics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5373ff64aa1eef86bcb53c3dadc242b
https://doi.org/10.1158/1078-0432.22460859.v1
https://doi.org/10.1158/1078-0432.22460859.v1
Autor:
Lajos Pusztai, Anees B. Chagpar, Donald Lannin, Erin W. Hofstatter, Maysa Abu-Khalaf, Kelly K. Hunt, Stacy L. Moulder, Rebekah E. Gould, Ya Zhang, W. Fraser Symmans, Christos Hatzis
Power calculations for extreme scenario
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34b5ed12e185abc449eaaba428848aa3
https://doi.org/10.1158/1078-0432.22460856.v1
https://doi.org/10.1158/1078-0432.22460856.v1